Mouse Kif1c Conditional Knockout Project (CRISPR/Cas9)

Total Page:16

File Type:pdf, Size:1020Kb

Load more

https://www.alphaknockout.com Mouse Kif1c Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Kif1c conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Kif1c gene (NCBI Reference Sequence: NM_153103 ; Ensembl: ENSMUSG00000020821 ) is located on Mouse chromosome 11. 23 exons are identified, with the ATG start codon in exon 3 and the TGA stop codon in exon 23 (Transcript: ENSMUST00000094499). Exon 6~11 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Kif1c gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP24-72D6 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for a reporter allele are viable, fertile and overtly normal and display normal motor-dependent retrograde Golgi apparatus-to-endoplasmic reticulum transport. Exon 6 starts from about 11.03% of the coding region. The knockout of Exon 6~11 will result in frameshift of the gene. The size of intron 5 for 5'-loxP site insertion: 579 bp, and the size of intron 11 for 3'-loxP site insertion: 552 bp. The size of effective cKO region: ~2171 bp. The cKO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 11 1 2 3 4 5 6 7 8 9 10 12 13 23 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Kif1c Homology arm cKO region loxP site Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(8671bp) | A(21.96% 1904) | C(25.1% 2176) | T(26.25% 2276) | G(26.7% 2315) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 8 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr11 + 70701209 70704208 3000 browser details YourSeq 84 2542 2643 3000 91.2% chr1 - 93077715 93077816 102 browser details YourSeq 27 169 198 3000 85.8% chr16 - 15934215 15934242 28 browser details YourSeq 22 1773 1796 3000 87.0% chr16 + 69985264 69985286 23 Note: The 3000 bp section upstream of Exon 6 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr11 + 70706380 70709379 3000 browser details YourSeq 144 1115 1312 3000 88.8% chr18 + 74735080 74735279 200 browser details YourSeq 138 1115 1312 3000 85.8% chr4 + 31818964 31819161 198 browser details YourSeq 136 1114 1309 3000 87.8% chr11 - 19672464 19672662 199 browser details YourSeq 136 1115 1312 3000 85.9% chr12 + 7686100 7686298 199 browser details YourSeq 136 1115 1310 3000 88.4% chr10 + 7597033 7597989 957 browser details YourSeq 135 1115 1309 3000 89.6% chr2 - 109744994 109745212 219 browser details YourSeq 134 1115 1308 3000 93.0% chr5 - 38018872 38019092 221 browser details YourSeq 133 1115 1278 3000 90.8% chr4 + 131695663 131695827 165 browser details YourSeq 132 1138 1312 3000 90.8% chr7 - 102495890 102496072 183 browser details YourSeq 132 1117 1309 3000 88.6% chr17 - 49132134 49132328 195 browser details YourSeq 131 1117 1319 3000 88.3% chr12 - 73509484 73509686 203 browser details YourSeq 131 1115 1321 3000 89.7% chr16 + 33712811 33713032 222 browser details YourSeq 131 1115 1314 3000 82.3% chr1 + 178209534 178209732 199 browser details YourSeq 130 1113 1309 3000 89.3% chr16 - 50744843 50745054 212 browser details YourSeq 130 1138 1305 3000 93.4% chr14 - 71965183 72096096 130914 browser details YourSeq 129 1115 1308 3000 86.1% chr9 - 72130419 72130654 236 browser details YourSeq 129 1117 1290 3000 89.6% chr15 - 79009244 79009420 177 browser details YourSeq 129 1113 1311 3000 85.8% chr4 + 121066150 121066350 201 browser details YourSeq 129 1110 1305 3000 87.0% chr4 + 114717311 114717515 205 Note: The 3000 bp section downstream of Exon 11 is BLAT searched against the genome. No significant similarity is found. Page 4 of 8 https://www.alphaknockout.com Gene and protein information: Kif1c kinesin family member 1C [ Mus musculus (house mouse) ] Gene ID: 16562, updated on 12-Aug-2019 Gene summary Official Symbol Kif1c provided by MGI Official Full Name kinesin family member 1C provided by MGI Primary source MGI:MGI:1098260 See related Ensembl:ENSMUSG00000020821 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as Ltxs1; Orch3; D11Bwg1349e; B430105J22Rik Expression Ubiquitous expression in heart adult (RPKM 50.0), colon adult (RPKM 41.5) and 27 other tissues See more Orthologs human all Genomic context Location: 11; 11 B3 See Kif1c in Genome Data Viewer Exon count: 24 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 11 NC_000077.6 (70700396..70731970) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 11 NC_000077.5 (70514050..70545472) Chromosome 11 - NC_000077.6 Page 5 of 8 https://www.alphaknockout.com Transcript information: This gene has 5 transcripts Gene: Kif1c ENSMUSG00000020821 Description kinesin family member 1C [Source:MGI Symbol;Acc:MGI:1098260] Gene Synonyms B430105J22Rik, D11Bwg1349e, N-3 kinsin, Orch3 Location Chromosome 11: 70,700,548-70,731,964 forward strand. GRCm38:CM001004.2 About this gene This gene has 5 transcripts (splice variants), 175 orthologues, 43 paralogues, is a member of 1 Ensembl protein family and is associated with 5 phenotypes. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Kif1c-203 ENSMUST00000102554.7 6684 1100aa ENSMUSP00000099614.1 Protein coding CCDS24965 O35071 TSL:5 GENCODE basic APPRIS P2 Kif1c-204 ENSMUST00000137119.2 6596 1100aa ENSMUSP00000123242.2 Protein coding CCDS24965 O35071 TSL:5 GENCODE basic APPRIS P2 Kif1c-202 ENSMUST00000094499.10 5168 1100aa ENSMUSP00000092075.4 Protein coding CCDS24965 O35071 TSL:1 GENCODE basic APPRIS P2 Kif1c-201 ENSMUST00000072187.11 5046 1112aa ENSMUSP00000072048.5 Protein coding - E9Q9B0 TSL:1 GENCODE basic APPRIS ALT2 Kif1c-205 ENSMUST00000152618.8 1943 425aa ENSMUSP00000136258.1 Protein coding - Q3V3Y9 TSL:1 GENCODE basic Page 6 of 8 https://www.alphaknockout.com 51.42 kb Forward strand 70.70Mb 70.71Mb 70.72Mb 70.73Mb 70.74Mb Genes (Comprehensive set... Kif1c-203 >protein coding Kif1c-205 >protein coding Kif1c-202 >protein coding Kif1c-201 >protein coding Kif1c-204 >protein coding Mir6925-201 >miRNA Contigs AL596117.19 > Genes < Inca1-201protein coding (Comprehensive set... < Inca1-205protein coding < Inca1-202protein coding < Inca1-203protein coding < Inca1-204protein coding Regulatory Build 70.70Mb 70.71Mb 70.72Mb 70.73Mb 70.74Mb Reverse strand 51.42 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Gene Legend Protein Coding merged Ensembl/Havana Ensembl protein coding Non-Protein Coding RNA gene Page 7 of 8 https://www.alphaknockout.com Transcript: ENSMUST00000094499 29.83 kb Forward strand Kif1c-202 >protein coding ENSMUSP00000092... MobiDB lite Low complexity (Seg) Coiled-coils (Ncoils) Superfamily P-loop containing nucleoside triphosphate hydrolase SMAD/FHA domain superfamily SMART Kinesin motor domain Prints Kinesin motor domain Pfam Kinesin motor domain Kinesin-associated Forkhead-associated (FHA) domain PROSITE profiles Kinesin motor domain PROSITE patterns Kinesin motor domain, conserved site PANTHER Kinesin-like protein PTHR24115:SF322 Gene3D Kinesin motor domain superfamily 2.60.200.20 CDD cd01365 Forkhead-associated (FHA) domain All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend missense variant synonymous variant Scale bar 0 100 200 300 400 500 600 700 800 900 1000 1100 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 8 of 8.
Recommended publications
  • HOOK3 Is a Scaffold for the Opposite-Polarity Microtubule-Based

    HOOK3 Is a Scaffold for the Opposite-Polarity Microtubule-Based

    bioRxiv preprint doi: https://doi.org/10.1101/508887; this version posted December 31, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. HOOK3 is a scaffold for the opposite-polarity microtubule-based motors cytoplasmic dynein and KIF1C Agnieszka A. Kendrick1, William B. Redwine1,2†, Phuoc Tien Tran1‡, Laura Pontano Vaites2, Monika Dzieciatkowska4, J. Wade Harper2, and Samara L. Reck-Peterson1,3,5 1Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, 92093. 2 Department of Cell Biology, Harvard Medical School, Boston, MA 02115. 3Section of Cell and Developmental Biology, Division of Biological Sciences, University of California San Diego, La Jolla, CA 92093. 4Department of Biochemistry and Molecular Genetics, University of Colorado Denver, Aurora, CO 80045. 5Howard Hughes Medical Institute †Present address: Stowers Institute for Medical Research, Kansas City, MO 64110 ‡Present address: Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138. *Correspondence to: Samara Reck-Peterson 9500 Gilman Drive, Leichtag 482 La Jolla CA, 92093 [email protected]; https://orcid.org/0000-0002-1553-465X 1 bioRxiv preprint doi: https://doi.org/10.1101/508887; this version posted December 31, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
  • Product Datasheet KIF1C Antibody NB100-57510

    Product Datasheet KIF1C Antibody NB100-57510

    Product Datasheet KIF1C Antibody NB100-57510 Unit Size: 0.1 ml Store at 4C. Do not freeze. Reviews: 1 Publications: 1 Protocols, Publications, Related Products, Reviews, Research Tools and Images at: www.novusbio.com/NB100-57510 Updated 3/16/2021 v.20.1 Earn rewards for product reviews and publications. Submit a publication at www.novusbio.com/publications Submit a review at www.novusbio.com/reviews/destination/NB100-57510 Page 1 of 3 v.20.1 Updated 3/16/2021 NB100-57510 KIF1C Antibody Product Information Unit Size 0.1 ml Concentration 0.2 mg/ml Storage Store at 4C. Do not freeze. Clonality Polyclonal Preservative 0.09% Sodium Azide Isotype IgG Purity Immunogen affinity purified Buffer TBS and 0.1% BSA Product Description Host Rabbit Gene ID 10749 Gene Symbol KIF1C Species Human, Mouse Immunogen The immunogen recognized by this antibody maps to a region between residue 1053 and the C-terminus (residue 1103) of human kinesin family member 1C (lethal toxin sensitivity 1) using the numbering given in entry NP_006603.2 (GeneID 10749). Product Application Details Applications Western Blot, Immunoprecipitation Recommended Dilutions Western Blot 1:2000-1:10000, Immunoprecipitation 2 - 5 ug/mg lysate Page 2 of 3 v.20.1 Updated 3/16/2021 Images Western Blot: KIF1C Antibody [NB100-57510] - KIF1C is a novel HOOK3 -interacting protein.sfGFP-3xFLAG and full length (FL) HOOK3, HOOK3 (1-552), and HOOK3 (553-718) all tagged with sfGFP and 3xFLAG were immunoprecipitated with alpha-FLAG antibodies from transiently transfected HEK-293T cells. Western blots with alpha-HC, alpha- FAM160A2, alpha-KIF1C, and alpha-FLAG antibodies were used to determine which proteins co-immunoprecipitated with each HOOK3 construct.DOI:http://dx.doi.org/10.7554/eLife.28257.015 Image collected and cropped by CiteAb from the following publication (https://elifesciences.org/articles/28257), licensed under a CC-BY licence.
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
  • S41467-020-18249-3.Pdf

    S41467-020-18249-3.Pdf

    ARTICLE https://doi.org/10.1038/s41467-020-18249-3 OPEN Pharmacologically reversible zonation-dependent endothelial cell transcriptomic changes with neurodegenerative disease associations in the aged brain Lei Zhao1,2,17, Zhongqi Li 1,2,17, Joaquim S. L. Vong2,3,17, Xinyi Chen1,2, Hei-Ming Lai1,2,4,5,6, Leo Y. C. Yan1,2, Junzhe Huang1,2, Samuel K. H. Sy1,2,7, Xiaoyu Tian 8, Yu Huang 8, Ho Yin Edwin Chan5,9, Hon-Cheong So6,8, ✉ ✉ Wai-Lung Ng 10, Yamei Tang11, Wei-Jye Lin12,13, Vincent C. T. Mok1,5,6,14,15 &HoKo 1,2,4,5,6,8,14,16 1234567890():,; The molecular signatures of cells in the brain have been revealed in unprecedented detail, yet the ageing-associated genome-wide expression changes that may contribute to neurovas- cular dysfunction in neurodegenerative diseases remain elusive. Here, we report zonation- dependent transcriptomic changes in aged mouse brain endothelial cells (ECs), which pro- minently implicate altered immune/cytokine signaling in ECs of all vascular segments, and functional changes impacting the blood–brain barrier (BBB) and glucose/energy metabolism especially in capillary ECs (capECs). An overrepresentation of Alzheimer disease (AD) GWAS genes is evident among the human orthologs of the differentially expressed genes of aged capECs, while comparative analysis revealed a subset of concordantly downregulated, functionally important genes in human AD brains. Treatment with exenatide, a glucagon-like peptide-1 receptor agonist, strongly reverses aged mouse brain EC transcriptomic changes and BBB leakage, with associated attenuation of microglial priming. We thus revealed tran- scriptomic alterations underlying brain EC ageing that are complex yet pharmacologically reversible.
  • The Rab6-Regulated KIF1C Kinesin Motor Domain Contributes to Golgi Organization Peter L Lee, Maikke B Ohlson†, Suzanne R Pfeffer*

    The Rab6-Regulated KIF1C Kinesin Motor Domain Contributes to Golgi Organization Peter L Lee, Maikke B Ohlson†, Suzanne R Pfeffer*

    RESEARCH ARTICLE elifesciences.org The Rab6-regulated KIF1C kinesin motor domain contributes to Golgi organization Peter L Lee, Maikke B Ohlson†, Suzanne R Pfeffer* Department of Biochemistry, Stanford University School of Medicine, Stanford, United States Abstract Most kinesins transport cargoes bound to their C-termini and use N-terminal motor domains to move along microtubules. We report here a novel function for KIF1C: it transports Rab6A-vesicles and can influence Golgi complex organization. These activities correlate with KIF1C’s capacity to bind the Golgi protein Rab6A directly, both via its motor domain and C-terminus. Rab6A binding to the motor domain inhibits microtubule interaction in vitro and in cells, decreasing the amount of motile KIF1C. KIF1C depletion slows protein delivery to the cell surface, interferes with vesicle motility, and triggers Golgi fragmentation. KIF1C can protect Golgi membranes from fragmentation in cells lacking an intact microtubule network. Rescue of fragmentation requires sequences that enable KIF1C to bind Rab6A at both ends, but not KIF1C motor function. Rab6A binding to KIF1C’s motor domain represents an entirely new mode of regulation for a kinesin motor, and likely has important consequences for KIF1C’s cellular functions. DOI: 10.7554/eLife.06029.001 *For correspondence: pfeffer@ stanford.edu Introduction Kinesin superfamily proteins (KIFs) are microtubule-based motors that are responsible for the Present address: †Genentech, motility of membrane-bound compartments and transport vesicles (Hirokawa et al., 2009b; South San Francisco, United States Verhey and Hammond, 2009). Of fundamental interest is how these motor proteins link to specific membrane cargoes and how they are regulated.
  • The Kinesin Superfamily Handbook Transporter, Creator, Destroyer

    The Kinesin Superfamily Handbook Transporter, Creator, Destroyer

    The Kinesin Superfamily Handbook Transporter, Creator, Destroyer Edited by Claire T. Friel First edition published 2020 ISBN: 978-1-138-58956-8 (hbk) ISBN: 978-0-429-49155-9 (ebk) 4 The Kinesin-3 Family Long-Distance Transporters Nida Siddiqui and Anne Straube CC BY-NC-ND 4.0 The Kinesin Superfamily Handbook The Kinesin-3 Family 4 Long-Distance Transporters Nida Siddiqui and Anne Straube CONTENTS 4.1 Example Family Members .............................................................................. 41 4.2 Structural Information .................................................................................... 41 4.3 Functional Properties ...................................................................................... 43 4.3.1 Autoinhibition of Kinesin-3 Motors and Their Activation .................45 4.4 Physiological Roles .........................................................................................46 4.4.1 Preference for Subsets of Microtubule Tracks .................................... 47 4.5 Involvement in Disease ...................................................................................48 Acknowledgements ..................................................................................................49 References ................................................................................................................49 The Kinesin-3s are a family of cargo transporters. They typically display highly processive plus-end-directed motion, either as dimers or in teams, formed via interaction with
  • Hereditary Spastic Paraplegia: from Genes, Cells and Networks to Novel Pathways for Drug Discovery

    Hereditary Spastic Paraplegia: from Genes, Cells and Networks to Novel Pathways for Drug Discovery

    brain sciences Review Hereditary Spastic Paraplegia: From Genes, Cells and Networks to Novel Pathways for Drug Discovery Alan Mackay-Sim Griffith Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111, Australia; a.mackay-sim@griffith.edu.au Abstract: Hereditary spastic paraplegia (HSP) is a diverse group of Mendelian genetic disorders affect- ing the upper motor neurons, specifically degeneration of their distal axons in the corticospinal tract. Currently, there are 80 genes or genomic loci (genomic regions for which the causative gene has not been identified) associated with HSP diagnosis. HSP is therefore genetically very heterogeneous. Finding treatments for the HSPs is a daunting task: a rare disease made rarer by so many causative genes and many potential mutations in those genes in individual patients. Personalized medicine through genetic correction may be possible, but impractical as a generalized treatment strategy. The ideal treatments would be small molecules that are effective for people with different causative mutations. This requires identification of disease-associated cell dysfunctions shared across geno- types despite the large number of HSP genes that suggest a wide diversity of molecular and cellular mechanisms. This review highlights the shared dysfunctional phenotypes in patient-derived cells from patients with different causative mutations and uses bioinformatic analyses of the HSP genes to identify novel cell functions as potential targets for future drug treatments for multiple genotypes. Keywords: neurodegeneration; motor neuron disease; spastic paraplegia; endoplasmic reticulum; Citation: Mackay-Sim, A. Hereditary protein-protein interaction network Spastic Paraplegia: From Genes, Cells and Networks to Novel Pathways for Drug Discovery. Brain Sci. 2021, 11, 403.
  • Data-Mining Approach for Screening of Rare Genetic Elements Associated

    Data-Mining Approach for Screening of Rare Genetic Elements Associated

    Turk J Biochem 2019; 44(6): 848–854 Research Article Muhammad Zubair Mahboob, Arslan Hamid, Nada Mushtaq, Sana Batool, Hina Batool, Nadia Zeeshan, Muhammad Ali, Kalsoom Sughra* and Naeem Mahmood Ashraf* Data-mining approach for screening of rare genetic elements associated with predisposition of prostate cancer in South-Asian populations Güney Asya Popülasyonlarında Prostat Kanseri Predispozisyonuyla İlişkili Nadir Genetik Elementlerin Taranmasında Veri Madenciliği Yaklaşımı https://doi.org/10.1515/tjb-2018-0454 Materials and methods: Genome-wide association studies Received November 9, 2018; accepted May 23, 2019; previously (GWAS) catalog and Gene Expression Omnibus (GEO) fur- published online August 30, 2019 nished PCa-related genetic studies. Database for Anno- Abstract tation, Visualization and Integrated Discovery (DAVID) functionally annotated these genes and wANNOVAR sep- Objective: Prostate cancer (PCa) is a complex heterogene- arated South Asian (SAS) populations – specific genetic ous disease and a major health risk to men throughout the factors at MAF threshold <0.05. world. The potential tumorigenic genetic hallmarks asso- Results: The study reports 195 genes as potential contribu- ciated with PCa include sustaining proliferative signaling, tors to prostate cancer in SAS populations. Some of iden- resisting cell death, aberrant androgen receptor signal- tified genes are PYGO2, RALBP1, RFX5, SLC22A3, VPS53, ing, androgen independence, and castration resistance. HMCN1 and KIF1C. Despite numerous comprehensive genome-wide associa- Conclusion: The identified genetic elements may assist in tion studies (GWAS), certain genetic elements associated development of population-specific screening and man- with PCa are still unknown. This situation demands more agement strategies for PCa. Moreover, this approach may systematic GWAS studies in different populations.
  • Download Ppis for Each Single Seed, Thus Obtaining Each Seed’S Interactome (Ferrari Et Al., 2018)

    Download Ppis for Each Single Seed, Thus Obtaining Each Seed’S Interactome (Ferrari Et Al., 2018)

    bioRxiv preprint doi: https://doi.org/10.1101/2021.01.14.425874; this version posted January 16, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Integrating protein networks and machine learning for disease stratification in the Hereditary Spastic Paraplegias Nikoleta Vavouraki1,2, James E. Tomkins1, Eleanna Kara3, Henry Houlden3, John Hardy4, Marcus J. Tindall2,5, Patrick A. Lewis1,4,6, Claudia Manzoni1,7* Author Affiliations 1: Department of Pharmacy, University of Reading, Reading, RG6 6AH, United Kingdom 2: Department of Mathematics and Statistics, University of Reading, Reading, RG6 6AH, United Kingdom 3: Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, United Kingdom 4: Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, WC1N 3BG, United Kingdom 5: Institute of Cardiovascular and Metabolic Research, University of Reading, Reading, RG6 6AS, United Kingdom 6: Department of Comparative Biomedical Sciences, Royal Veterinary College, London, NW1 0TU, United Kingdom 7: School of Pharmacy, University College London, London, WC1N 1AX, United Kingdom *Corresponding author: [email protected] Abstract The Hereditary Spastic Paraplegias are a group of neurodegenerative diseases characterized by spasticity and weakness in the lower body. Despite the identification of causative mutations in over 70 genes, the molecular aetiology remains unclear. Due to the combination of genetic diversity and variable clinical presentation, the Hereditary Spastic Paraplegias are a strong candidate for protein- protein interaction network analysis as a tool to understand disease mechanism(s) and to aid functional stratification of phenotypes.
  • PTPN21 and Hook3 Relieve KIF1C Autoinhibition and Activate Intracellular Transport

    PTPN21 and Hook3 Relieve KIF1C Autoinhibition and Activate Intracellular Transport

    ARTICLE https://doi.org/10.1038/s41467-019-10644-9 OPEN PTPN21 and Hook3 relieve KIF1C autoinhibition and activate intracellular transport Nida Siddiqui 1,2,5, Alexander James Zwetsloot 1,3,5, Alice Bachmann1,2, Daniel Roth 1,2, Hamdi Hussain 1,2, Jonathan Brandt 1,2, Irina Kaverina4 & Anne Straube 1,2 The kinesin-3 KIF1C is a fast organelle transporter implicated in the transport of dense core vesicles in neurons and the delivery of integrins to cell adhesions. Here we report the 1234567890():,; mechanisms of autoinhibition and release that control the activity of KIF1C. We show that the microtubule binding surface of KIF1C motor domain interacts with its stalk and that these autoinhibitory interactions are released upon binding of protein tyrosine phosphatase PTPN21. The FERM domain of PTPN21 stimulates dense core vesicle transport in primary hippocampal neurons and rescues integrin trafficking in KIF1C-depleted cells. In vitro, human full-length KIF1C is a processive, plus-end directed motor. Its landing rate onto microtubules increases in the presence of either PTPN21 FERM domain or the cargo adapter Hook3 that binds the same region of KIF1C tail. This autoinhibition release mechanism allows cargo- activated transport and might enable motors to participate in bidirectional cargo transport without undertaking a tug-of-war. 1 Centre for Mechanochemical Cell Biology, University of Warwick, Coventry CV4 7AL, UK. 2 Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK. 3 MRC-DTP in Interdisciplinary Biomedical Research, Warwick Medical School, Coventry CV4 7AL, UK. 4 Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville 37232 TN, USA.
  • Decreased DNA Methylation at Promoters and Gene-Specific Neuronal

    Decreased DNA Methylation at Promoters and Gene-Specific Neuronal

    medRxiv preprint doi: https://doi.org/10.1101/2020.12.10.20246405; this version posted December 11, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Decreased DNA methylation at promoters and gene-specific neuronal hypermethylation in the prefrontal cortex of patients with bipolar disorder Miki Bundo1†, Junko Ueda1,2†, Yutaka Nakachi1, Kiyoto Kasai3,4, Tadafumi Kato2,5#, Kazuya Iwamoto1# 1Department of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Japan 2Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Center for Brain Science, Japan 3Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Japan 4The International Research Center for Neurointelligence (WPI-IRCN) at The University of Tokyo Institutes for Advanced Study (UTIAS), 5Department of Psychiatry and Behavioral Science, Graduate School of Medicine, Juntendo University †contributed equally to this work #corresponding authors: Kazuya Iwamoto Department of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University. 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan [email protected] Tadadumi Kato Department of Psychiatry and Behavioral Science, Graduate School of Medicine, Juntendo University. 2-1-1 Hongo, Bunkyo, Tokyo 113-8421, Japan [email protected]. Running title: DNA methylation analysis in bipolar disorder 1 NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.10.20246405; this version posted December 11, 2020.
  • Activation of Intracellular Transport by Relieving KIF1C Autoinhibition

    Activation of Intracellular Transport by Relieving KIF1C Autoinhibition

    bioRxiv preprint doi: https://doi.org/10.1101/488049; this version posted December 6, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Activation of intracellular transport by relieving KIF1C autoinhibition Nida Siddiqui1,2, Alice Bachmann1,2, Alexander James Zwetsloot1,3, Hamdi Hussain1,2, Daniel Roth1,2, Irina Kaverina4 and Anne Straube1,2,* 1 Centre for Mechanochemical Cell Biology, University of Warwick, Coventry, CV4 7AL, UK 2 Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK 3 MRC-DTP in Interdisciplinary Biomedical Research, Warwick Medical School, Coventry, CV4 7AL, UK 4 Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville 37232, TN, USA * correspondence to [email protected]; +44 (0) 2476 151 169 Abstract The kinesin-3 KIF1C is a fast organelle transporter implicated in the transport of dense core vesicles in neurons and the delivery of integrins to cell adhesions. Here we report the mechanisms of autoinhibition and release that control the activity of KIF1C. We show that the microtubule binding surface of KIF1C motor domain interacts with its stalk and that these autoinhibitory interactions are released upon binding of protein tyrosine phosphatase PTPN21. The FERM domain of PTPN21 stimulates dense core vesicle transport in primary hippocampal neurons and rescues integrin trafficking in KIF1C-depleted cells. In vitro, human full-length KIF1C is a processive, plus-end directed motor. Its landing rate onto microtubules increases in the presence of either PTPN21 FERM domain or the cargo adapter Hook3 that binds the same region of KIF1C tail.